SENTION THERAPEUTICS Trademark

Trademark Overview

On Wednesday, September 8, 2021, a trademark application was filed for SENTION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SENTION THERAPEUTICS trademark a serial number of 97017685. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, February 16, 2024. This trademark is owned by Sention Therapeutics, LLC. The SENTION THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and prescription medicines for use in treating disorders of the endocrine system

General Information

Serial Number97017685
Word MarkSENTION THERAPEUTICS
Filing DateWednesday, September 8, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, February 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and prescription medicines for use in treating disorders of the endocrine system
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 18, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSention Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121
Party NameSention Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92122

Trademark Events

Event DateEvent Description
Saturday, September 11, 2021NEW APPLICATION ENTERED
Friday, September 17, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 17, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 17, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 17, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, June 12, 2022ASSIGNED TO EXAMINER
Friday, June 17, 2022NON-FINAL ACTION E-MAILED
Friday, June 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 17, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 22, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, June 22, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 22, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 22, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, June 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Friday, March 3, 2023SOU EXTENSION 1 FILED
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 3, 2023SOU EXTENSION 1 GRANTED
Sunday, September 10, 2023SOU EXTENSION 2 FILED
Sunday, September 10, 2023SOU EXTENSION 2 GRANTED
Tuesday, September 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 10, 2023SOU TEAS EXTENSION RECEIVED
Friday, February 16, 2024SOU EXTENSION 3 GRANTED
Saturday, February 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2024SOU EXTENSION 3 FILED
Friday, February 16, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

therapeutics sention disorders endocrine system treating medicines preparations prescription pharmaceutical